Alerts will be sent to your verified email
Verify EmailPOSITRON
|
Positron Energy
|
Anand Rayons
|
Novelix Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
28.49 % | 7.03 % | 0.0 |
|
5yr average Equity Multiplier
|
2.58 | 2.16 | 1.26 |
|
5yr Average Asset Turnover Ratio
|
2.01 | 3.9 | 0.84 |
|
5yr Avg Net Profit Margin
|
5.86 % | 0.84 % | -14.11 % |
|
Price to Book
|
0.0 | 1.18 | 15.84 |
|
P/E
|
6.41 | 12.12 | 62.35 |
|
5yr Avg Cash Conversion Cycle
|
12.01 Days | 57.73 Days | 29.1 Days |
|
Inventory Days
|
14.67 Days | 9.66 Days | 34.04 Days |
|
Days Receivable
|
25.28 Days | 52.39 Days | 55.38 Days |
|
Days Payable
|
26.53 Days | 9.36 Days | 55.7 Days |
|
5yr Average Interest Coverage Ratio
|
12.35 | 2.22 | -17.77 |
|
5yr Avg ROCE
|
25.69 % | 15.15 % | -15.4 % |
|
5yr Avg Operating Profit Margin
|
7.82 % | 2.17 % | -16.49 % |
|
5 yr average Debt to Equity
|
0.7 | 0.88 | 0.05 |
|
5yr CAGR Net Profit
|
138.58 % | 36.96 % | 35.78 % |
|
5yr Average Return on Assets
|
11.43 % | 3.33 % | -13.36 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.2 % | 52.57 % | 49.43 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.2 % | -17.27 % | -17.49 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Positron Energy
|
Anand Rayons
|
Novelix Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Product Wise Break-Up
|